ASTCT Presents Distinguished Honors at the 2022 Tandem Meetings
27 avr. 2022 09h00 HE
|
American Society for Transplantation and Cellular Therapy
SALT LAKE CITY, April 27, 2022 (GLOBE NEWSWIRE) -- American Society for Transplantation and Cellular Therapy (ASTCT) presented top awards to leaders in the field of transplantation and cellular...
Brenda M. Sandmaier, M.D., Named ASTCT 2022-2023 President
26 avr. 2022 09h00 HE
|
American Society for Transplantation and Cellular Therapy
CHICAGO, April 26, 2022 (GLOBE NEWSWIRE) -- American Society for Transplantation and Cellular Therapy (ASTCT) announced Brenda M. Sandmaier, M.D., as the ASTCT President in 2022-2023. Dr....
ExCellThera announces new data to be presented at the EBMT 2022 annual meeting
15 mars 2022 08h04 HE
|
ExCellThera
MONTRÉAL, March 15, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a clinical-stage cell expansion and engineering company delivering molecules and bioengineering solutions to expand...
ExCellThera announces first patient treated in Phase I/II trial of ECT-001 cell therapy for pediatric patients with high risk blood cancer
10 mars 2022 08h04 HE
|
ExCellThera
MONTREAL, March 10, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a clinical-stage cell expansion and engineering company delivering molecules and bioengineering solutions to expand and...
Antibody Drug Conjugates (ADCs) Market Size to Reach USD 13.17 Billion by 2028 - Powered by Approval for Biologics License Applications – Vantage Market Research
15 févr. 2022 04h39 HE
|
Vantage Market Research
WASHINGTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Antibody Drug Conjugates (ADCS) Market finds that granted accelerated approval for biologics...
$4.31 Billion Worldwide Hematology Analyzers and Reagents Industry to 2030 - Identify Growth Segments for Investment
30 déc. 2021 05h33 HE
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD Testing with the clonoSEQ® Assay in Patients with Blood Cancers at the 63rd ASH Annual Meeting
13 déc. 2021 16h05 HE
|
Adaptive Biotechnologies
Analysis of the MASTER trial (Abstract 481) showed clonoSEQ’s ability to measure deep and durable responses and permit treatment discontinuation in multiple myeloma patientsData in more than 30...
ExCellThera announces data to be presented at the American Society of Hematology 2021 annual meeting
29 nov. 2021 08h05 HE
|
ExCellThera
MONTRÉAL, Nov. 29, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage cell expansion and engineering company delivering molecules and bioengineering solutions to expand and engineer...
3-Year Global MPN Interferon Initiative Report Released by MPN Research Foundation
01 nov. 2021 08h45 HE
|
MPN Research Foundation
Chicago, IL, Nov. 01, 2021 (GLOBE NEWSWIRE) -- In real-world usage and in clinical trials, interferon (IFN) in a variety of forms has shown high rates of hematologic and molecular responses in many...
The MDS Foundation Celebrates MDS World Awareness Day With Their 4th Annual Move for MDS 5k Walk at Boston Common and Virtually Around the World
20 oct. 2021 10h05 HE
|
MDS Foundation, Inc.
YARDVILLE, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- The MDS Foundation, a global non-profit advocacy organization is proud to announce its fourth annual Move for MDS walk at Boston Common on Sunday,...